Xanthohumol and Related Prenylated Flavonoids Inhibit Inflammatory Cytokine Production in LPS-Activated THP-1 Monocytes: Structure-Activity Relationships and In Silico Binding to Myeloid Differentiation Protein-2 (MD-2)

 

 Buy Article Permissions and Reprints

Abstract

Xanthohumol (XN) is a prenylated chalcone-type flavonoid found in hops and beer. Our objective of this study was to determine the anti-inflammatory activities of XN, isoxanthohumol (IX), and 15 related prenylated chalcones and flavanones, as well as their structure-activity relationships. The anti-inflammatory activities of the flavonoids were measured by their ability to inhibit lipopolysaccharide (LPS)-induced cytokine production in human monocytic THP-1 cells. The position, number, and length of the prenyl groups had a marked influence on the inhibitory activity of the prenylfavonoids towards MCP-1 and IL-6 production. The α,β-unsaturated carbonyl moiety present in chalcones such as XN was not an absolute requirement for inhibitory activity, as the saturated XN derivative, tetrahydroxanthohumol (TX), showed inhibitory activity comparable to XN. With the aim to determine the mechanism of the observed anti-inflammatory effects, cellular protein levels of Toll-like receptor 4 (TLR4) were measured by Western blot 24 h following coexposure of THP-1 cells to LPS and either XN, TX, or IX. Only XN reduced the cellular TLR4 protein content. Therefore, an additional hypothesis was developed for an anti-inflammatory mechanism that involves the TLR4 coreceptor myeloid differentiation protein-2 (MD-2), which provides the actual binding site for LPS. Molecular docking studies showed that the complementarity of prenylated flavonoids with the hydrophobic MD-2 pocket (indicating goodness of fit) directly predicted their relative ability to inhibit MCP-1 and IL-6 production. In conclusion, prenylated flavonoids may suppress LPS-induced TLR4 activation at least partly by interfering with LPS binding to the TLR4 coreceptor MD-2, and XN (but not other prenylflavonoids) exerts an additional anti-inflammatory effect by downregulating the cellular TLR4 protein content.

References

• 1 Stevens J F, Page J E. Xanthohumol and related prenylflavonoids from hops and beer: to your good health!.  Phytochemistry. 2004;  65 1317-1330
  CrossrefPubMedGoogle Scholar
• 2 Stevens J F, Taylor A W, Clawson J E, Deinzer M L. Fate of xanthohumol and related prenylflavonoids from hops to beer.  J Agric Food Chem. 1999;  47 2421-2428
  CrossrefPubMedGoogle Scholar
• 3 Stevens J F, Taylor A W, Deinzer M L. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry.  J Chromatogr A. 1999;  832 97-107
  CrossrefPubMedGoogle Scholar
• 4 Stevens J F, Taylor A W, Nickerson G B, Ivancic M, Henning J, Haunold A, Deinzer M L. Prenylflavonoid variation in Humulus lupulus: distribution and taxonomic significance of xanthogalenol and 4′-O-methylxanthohumol.  Phytochemistry. 2000;  53 759-775
  CrossrefPubMedGoogle Scholar
• 5 Miranda C L, Stevens J F, Helmrich A, Henderson M C, Rodriguez R J, Yang Y H, Deinzer M L, Barnes D W, Buhler D R. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines.  Food Chem Toxicol. 1999;  37 271-285
  CrossrefPubMedGoogle Scholar
• 6 Miranda C L, Stevens J F, Ivanov V, McCall M, Frei B, Deinzer M L, Buhler D R. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro.  J Agric Food Chem. 2000;  48 3876-3884
  CrossrefPubMedGoogle Scholar
• 7 Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis.  Annu Rev Immunol. 2009;  27 165-197
  CrossrefPubMedGoogle Scholar
• 8 Gay N J, Gangloff M. Structure and function of Toll receptors and their ligands.  Annu Rev Biochem. 2007;  76 141-165
  CrossrefPubMedGoogle Scholar
• 9 Akira S, Takeda K. Toll-like receptor signalling.  Nat Rev Immunol. 2004;  4 499-511
  CrossrefPubMedGoogle Scholar
• 10 Kim H M, Park B S, Kim J I, Kim S E, Lee J, Oh S C, Enkhbayar P, Matsushima N, Lee H, Yoo O J, Lee J O. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.  Cell. 2007;  130 906-917
  CrossrefPubMedGoogle Scholar
• 11 Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution.  Nat Immunol. 2002;  3 667-672
  PubMedGoogle Scholar
• 12 Triantafilou M, Brandenburg K, Kusumoto S, Fukase K, Mackie A, Seydel U, Triantafilou K. Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses.  Biochem J. 2004;  381 527-536
  CrossrefPubMedGoogle Scholar
• 13 Calixto J B, Campos M M, Otuki M F, Santos A R. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules.  Planta Med. 2004;  70 93-103
  Article in Thieme ConnectPubMedGoogle Scholar
• 14 Cho Y C, Kim H J, Kim Y J, Lee K Y, Choi H J, Lee I S, Kang B Y. Differential anti-inflammatory pathway by xanthohumol in IFN-γ and LPS-activated macrophages.  Int Immunopharmacol. 2008;  8 567-573
  CrossrefPubMedGoogle Scholar
• 15 Zhao F, Nozawa H, Daikonnya A, Kondo K, Kitanaka S. Inhibitors of nitric oxide production from hops (Humulus lupulus L.).  Biol Pharm Bull. 2003;  26 61-65
  CrossrefPubMedGoogle Scholar
• 16 Lupinacci E, Meijerink J, Vincken J P, Gabriele B, Gruppen H, Witkamp R F. Xanthohumol from hop (Humulus lupulus L.) is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-α release in LPS-stimulated RAW 264.7 mouse macrophages and U937 human monocytes.  J Agric Food Chem. 2009;  57 7274-7281
  CrossrefPubMedGoogle Scholar
• 17 Stevens J F, Ivancic M, Hsu V, Deinzer M L. Prenylflavonoids from Humulus lupulus.  Phytochemistry. 1997;  44 1575-1585
  CrossrefPubMedGoogle Scholar
• 18 Schuttelkopf A W, van Aalten D M F. PRODRG – a tool for high-throughput crystallography of protein-ligand complexes.  Acta Crystallogr. 2004;  D60 1355-1363
  PubMedGoogle Scholar
• 19 Park B S, Song D H, Kim H M, Choi B S, Lee H, Lee J O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.  Nature. 2009;  458 1191-1195
  CrossrefPubMedGoogle Scholar
• 20 Morris G M, Halliday R S, Huey R, Hart W E, Belew R K, Olson A J. Automated docking using a lamarckian genetic algorithm and empirical binding free energy function.  J Comput Chem. 1998;  19 1639-1662
  CrossrefPubMedGoogle Scholar
• 21 Sobolev V, Sorokine A, Prilusky J, Abola E E, Edelman M. Automated analysis of interatomic contacts in proteins.  Bioinformatics. 1999;  15 327-332
  CrossrefPubMedGoogle Scholar
• 22 DeLano W L. The PyMOL molecular graphics system. Palo Alto; DeLano Scientific 2002
  PubMedGoogle Scholar
• 23 Schmelzer C, Lorenz G, Rimbach G, Doring F. In vitro effects of the reduced form of coenzyme Q₁₀ on secretion levels of TNF-α and chemokines in response to LPS in the human monocytic cell line THP-1.  J Clin Biochem Nutr. 2009;  44 62-66
  CrossrefPubMedGoogle Scholar
• 24 Gradisar H, Keber M M, Pristovsek P, Jerala R. MD-2 as the target of curcumin in the inhibition of response to LPS.  J Leukoc Biol. 2007;  82 968-974
  CrossrefPubMedGoogle Scholar
• 25 Kim H P, Son K H, Chang H W, Kang S S. Anti-inflammatory plant flavonoids and cellular action mechanisms.  J Pharmacol Sci. 2004;  96 229-245
  CrossrefPubMedGoogle Scholar
• 26 Garcia-Lafuente A, Guillamon E, Villares A, Rostagno M A, Martinez J A. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease.  Inflamm Res. 2009;  58 537-552
  CrossrefPubMedGoogle Scholar
• 27 Yoon J H, Baek S J. Molecular targets of dietary polyphenols with anti-inflammatory properties.  Yonsei Med J. 2005;  46 585-596
  CrossrefPubMedGoogle Scholar
• 28 Shanmugam K, Holmquist L, Steele M, Stuchbury G, Berbaum K, Schulz O, Benavente Garcia O, Castillo J, Burnell J, Garcia Rivas V, Dobson G, Munch G. Plant-derived polyphenols attenuate lipopolysaccharide-induced nitric oxide and tumour necrosis factor production in murine microglia and macrophages.  Mol Nutr Food Res. 2008;  52 427-438
  CrossrefPubMedGoogle Scholar
• 29 Albini A, Dell'Eva R, Vene R, Ferrari N, Buhler D R, Noonan D M, Fassina G. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-κB and Akt as targets.  Faseb J. 2006;  20 527-529
  PubMedGoogle Scholar
• 30 Gao X, Deeb D, Liu Y, Gautam S, Dulchavsky S A, Gautam S C. Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-κB.  Immunopharmacol Immunotoxicol. 2009;  31 477-484
  CrossrefPubMedGoogle Scholar
• 31 Harikumar K B, Kunnumakkara A B, Ahn K S, Anand P, Krishnan S, Guha S, Aggarwal B B. Modification of the cysteine residues in IκBα kinase and NF-κB (p 65) by xanthohumol leads to suppression of NF-κB-regulated gene products and potentiation of apoptosis in leukemia cells.  Blood. 2009;  113 2003-2013
  CrossrefPubMedGoogle Scholar

Prof. Ph.D. Jan Frederik Stevens

Oregon State University
Pharmaceutical Sciences 203 Pharmacy Building

1601 SW Jefferson

Corvallis, OR 97331

United States

Phone: + 1 54 17 37 95 34

Fax: + 1 54 17 37 39 99

Email: fred.stevens@oregonstate.edu